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Introduction
The search of effective treatments for neurodegenerative diseases is one of the urgent clinical and social needs today given their widespread and devastating nature. As most neurodegenerative disorders are age-dependent, due to longer life expectancy the prevalence of these diseases, including Alzheimer's and Parkinson's disease among others, increases daily. Common characteristics of neurodegenerative diseases include the progressive loss of neurons in specific regions of the nervous system underlying the subsequent decline in cognitive or motor function in patients. Given their largely unknown etiology and the lack of effective treatments there is a critical need to better understand the underlying disease pathophysiology and discover effective diseasemodifying targets for their treatment.
Genetic studies carried on several families in Asia, the United States, and
Europe led to discover in 2004 that mutations in the gene LRRK2 encoding leucine-rich repeat kinase 2 (LRRK2) as a major genetic risk factor for both familial and sporadic
Parkinson's disease (PD) 1 . Up to date among the disease-linked genetic polymorphisms (15% of the total PD population) LRRK2 mutations account for 4% of the cases and 1% of the sporadic ones 2 . Although these incidences are quite low and it remains unclear how mutations in LRRK2 gene cause PD-related neurodegeneration, LRRK2 has raised as one of the most pursued targets for PD and its inhibition has been proposed to be beneficial for preventing neurodegeneration. Big efforts are being done at the moment both from academia and the pharmaceutical industry with the goal of developing selective and brain-permeable LRRK2 inhibitors as neuroprotective agents for PD [3] [4] .
LRRK2 is an unusually large (2527 amino acids) protein that is classified as a member of the Ras-like GTPase (ROCO) superfamily. At least 6 independent domains have been established including a kinase domain, a GTPase domain and several proteinprotein interacting regions 5 . The physiological role of LRRK2 is poorly understood and many of its substrates remain unclear, however, great success was achieved by the identification of a subset of Rab GTPases as key LRRK2 substrates 6 . The downstream signals in which LRRK2 is involved are not well characterized yet, however LRRK2
can be related to other pathological pathways outside the direct PD pathology. LRRK2
can be related to tau pathology, inflammatory response, oxidative stress, mitochondrial M A N U S C R I P T
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and synaptic dysfunction, deficiencies in the autophagy-lysosomal system 7 and its implication in adult neurogenesis through the Wnt signaling pathway 8 .
Among these connections we considered as the most interesting one, the hypothesis that the pharmacological inhibition of LRRK2 may induce adult neurogenesis. There is evidence suggesting that neurogenesis is impaired in many neurodegenerative diseases, therapeutic approaches that stimulate neurogenesis may have potential to stimulate repair and even recovery, thereby providing innovative, disease-modifying treatments [9] [10] . Therefore, LRRK2 inhibitors may have a dual therapeutic role: the first one due to the direct beneficial effect of LRRK2 inhibition and the second one as enhancing adult neurogenesis.
Based on these collective observations pointing to the critical role of LRRK2 in CNS function and connections to proneurogenic pathways like Wnt signaling 8 , we initiated a medicinal chemistry program with the aim of finding new selective LRRK2
inhibitors with physicochemical properties compatible with crossing the blood brain barrier (BBB). Furthermore, we have used them as pharmacological probes of adult neurogenesis activators using neural stem cells isolated from the neurogenic niche of the adult mouse ventricular-subventricular zone 11 . In this communication we present a class of outstanding novel LRRK2 inhibitors that show a preliminary effect in increasing the proliferation of neural stem cells from the subventricular zone of adult mice and can therefore be considered as chemical probes to study the neuroregeneration potential of the damaged brain.
Results and discussion
Design of new compounds
Biology-oriented synthesis 12 employs chemical privileged scaffolds from natural sources for the development of focused libraries because natural products are particularly important as source of inspiration for new compounds 13 . A literature survey identified several isatin (1H-indole-2,3-dione) derivatives as, a natural scaffold present in different Chinese traditional medicines, with potent biological activity on different protein kinases (Figure 1 ) 14 . Moreover, some of them such as sunitinib are FDA approved for human therapy while semaxanib is currently in clinical trials (Figure 1 ) 15 . For the design of new LRRK2 inhibitors, we decided to keep the indolinone ring as common and privileged scaffold and to modify the nature of the atom directly joined to the oxindole ring introducing a nitrogen atom instead of the carbon atom present in the compounds of Figure 1 . Furthermore, the influence of various substituents on the aryl group was explored obtaining different compounds, with aromatic and aliphatic nature. In addition, the linker between the above mentioned substituent and the oxoindole heterocycle was modified. Imines and hydrazones were used for this purpose. 
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Chemistry
Preparation of the first family of these compounds was carried out using classical conditions to conduct the imine formation reaction between the isatin core and the corresponding aromatic amine under reflux in toluene and with 4-toluensulfonic acid as catalyst 16 . Several imino indolinone derivatives have been previously described.
However, due to long reaction times and low yields, new synthetic reaction conditions were looked for. Microwave assisted organic synthesis in the absence of solvent and montmorillonite (MMT-K10) as surface catalyst were the best option found 17 , although
here an optimized work-up was used (described in the experimental part). MMT-K10 is a mixture of silicates in laminar arrangement recently used as inorganic base in organic synthesis. The reactions catalysed by MMT-K10 are normally performed under mild conditions to obtain high yield and selectivity. MMT-K10 was not only used as a base but also as a solid surface where the reaction took place 18 . For imine formation it is essential to remove the water from the reaction medium and normally 4-toluenesulfonic acid was used. In our case, the use of microwave assisted organic synthesis accelerates the dehydration of the reaction using a clay support MMT-K10. Thus, lower reaction times (10 min) and an increase in general yield was achieved except for compounds 7
and 9 where the amine employed was in the hydrochloride form. The second family of compounds bears in their chemical structure aliphatic cyclic scaffolds as piperidine, morpholine or diphenylhydrazine among others (16) (17) (18) (19) (20) (21) instead of a phenyl ring. This involves a change in the nature of the linker to the isatin core from an imino to a hydrazone one (Scheme 1).
In order to explore the importance of the nitrogen atom of the isatin derivative, we N-alkylated the previously synthetized compounds employing classical conditions 19 which led us to derivatives 22-27. Nevertheless, in the case of imine derivatives, acidic medium leads to the hydrolysis of the imine bond. For this reason, the N-alkylation of the isatin heterocycle was done previously to the imine formation leading to compounds
28-29. Further reactions with different anilines yielded the desired compounds 30-32
(Scheme 1).
Finally, to introduce an alternative diversity point, the isatin core with different substituents in positions 5 and 7 were used as starting materials leading to the final products 33-50.
All the synthesized compounds were carefully characterized by mass spectra (MS), 1 H and 13 C-NMR including bidimensional HMBC and HSQC experiments, and when possible for some previously described compounds, melting points were compared (see experimental). Elemental analysis was performed for all the new herein reported compounds (see supporting information Table S1 ).
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The indolinones with imino or hydrazone bond directly attached to the heterocyclic framework may present two different isomers E and Z that were identified and quantified by 1 H-NMR (Table 1) . In order to determine the main isomer, a nuclear
Overhauser effect (nOe) experiment was carried out. Thus, by irradiation performed in the indolinone H4 proton, a nOe effect of the aromatic protons of the phenyl ring is observed for the E-isomer, while it is not detected for the Z-isomer (Figure 3 ). This methodology was carried out in all the cases to determine the isomers ratio of the compounds. For the first family of synthesized compounds, the oxoindole iminoderivatives 1-15 and 30-32, the main isomer obtained was the E form although the Z one was also detected. Differences observed in the isomers ratio could be justify by the electron donor or electron acceptor substituents present on the phenyl ring. However for compounds 17 and 18, the main isomer was found to be the Z one. In these compounds an intramolecular hydrogen bond could be formed between the carbonyl group of the indolinone core and the CH or NH of the imino or hydrazine bond, respectively.
In compounds where the hydrazone linker was present (derivatives 16, 19-27, 33-38), nOe experiments revealed that the main and in some cases such as compounds 37 and 38, the only isomer obtained was the E one due to the hydrogen bond formation between the H4 proton of the indolinone core and the nitrogen atom of the hydrazone moiety. If any substituents are present in the indolinone heterocycle, their piperidine (39) (40) (41) (42) (43) or morpholine (44-50) derivatives lead to obtain the Z isomer as the majority.
However, when there is no substitution in the oxoindole core, both isomers E and Z are found in the same ratios (see compounds 19, 24, 26, 27) ( Table 1) . Some representative 1 H-NMR spectra are collected in the supplementary information ( Figure S1 ). 
Kinase inhibition activity evaluation
All the synthetized indolinone compounds were evaluated as potential inhibitors of LRRK2. The assays were performed using LifeTechnologies Adapta® methodology according to the procedure described in the experimental section. This is a fluorescentbased immunoassay for the detection of ADP formed by the kinase reaction. Human recombinant LRRK2 and its substrate known as LRRKtide peptide (sequence: RLGRDKYKTLRQIRQ) were incubated in the presence or absence of inhibitors, and the ADP formed was quantified using specific antibodies resulting in a TR-FRET signal variation. All the compounds were assayed twice at a fixed concentration of 10 µM using the commercial compound lrrk2-in-1 as reference standard. When the percentage of inhibition was more than 50%, the dose response curve was determined and the IC 50 value calculated. Moreover, compounds that inhibit LRRK2 were also assayed in human recombinant LRRK2 G2019S, the most common LRRK2 mutation in familial M A N U S C R I P T
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able to inhibit this mutated form with similar potency even with PD-linked mutation being located in activation loop 22 . All the data are collected in Table 1 . Since one of the main challenges in kinase inhibitor discovery is the selectivity, and being aware that the central scaffold of our compounds is also present in other protein kinase inhibitors (Figure 1 ), we performed a kinase profiling with the first indolinone-like LRRK2 inhibitor here prepared (16) figure 1 , were included. Thus the inhibitory activity on different CK1
isoforms and EGFR, IGF1R and PDGFR alpha as representatives of tyrosin kinases were evaluated. Detailed experimental background such as ATP concentration and quantity of each enzyme used are described in the supporting information (Table S2) .
Selected protein kinases and the percentage of kinase activity remained after compound 16 treatment is depicted in Figure 4 . High selectivity towards LRRK2 inhibition was observed for indolinone derivative 16, which only showed a slight inhibition on the FMS-like tyrosine kinase 3 (FLT-3), pointing to a selective family of inhibitors. FLT-3 is involved and aberrantly active in acute myeloid leukemia 23 . To assure this selectivity profile, a second indolinone was selected to run the same panel. In that case, our criteria were to be a potent inhibitor and to have good drug like properties such the permeability in the central nervous system (CNS). Kinase selectivity for this family of compounds was confirmed when the isatin-like compound 38 was used ( Figure 4) . In order to gain insight into the binding mode of this new family of potent LRRK2 inhibitors, and looking for clues to assist in the lead-to-candidate optimization, a docking study using Glide XP (Schrödinger suite program) that allows examining a potential binding mode to the enzyme was carried out. The kinase domain of LRRK2
has not been crystallized but a LRRK2 homology model has recently been published 24 .
We reproduced the LRRK2 homology model using the crystal structure of Janus Kinase 
Prediction of blood brain barrier (BBB) permeability
As one of the main obstacles for the treatment of the diseases of the central nervous system (CNS) is the drug's penetration into the blood-brain barrier (BBB) at therapeutic concentrations, we decided to explore the prediction of our top indolinonebased LRRK2 inhibitors to penetrate into the human BBB. Parallel artificial membrane permeability assay (PAMPA) is a high-throughput technique developed to predict passive permeability through biological membranes 25 , and we used this methodology to 
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we could classify compounds as CNS+ when they present a permeability >3.54×10 −6 cm.s −1 . The in vitro permeabilities (Pe) of commercial drugs through lipid membrane extract together with those belonging to indolinones derivatives were determined as described in Table 1 and Supporting information Table S3 . Although calculated prediction to cross the BBB was positive for all the compounds, solubility problems were encountered for compounds 33, 34 and 36 and the prediction of BBB permeability was not possible to be determined. The low solubility of these compounds may be explained considering the predicted values of octanol/water partition coefficient (log p), polar surface area (PSA) and aqueous solubility (log S) calculated by QuickPro program for compounds 33, 34, 36 and 38 (see supporting information Table S4 ). More than one order of magnitude was found in log S between 38 and 33, 34 and 36 although their chemical structures are very similar, pointing to a better solubility for derivative 38.
Thus, as many of the LRRK2 inhibitors tested are predicted to cross the BBB by PAMPA assay they have potential for further pharmaceutical development including in vivo studies of CNS diseases.
Neurogenic properties of LRRK2 inhibitors
Adult NSCs continuously generate neurons throughout life in two brain regions:
the subgranular zone of the hippocampus and the V-SVZ, adjacent to the lateral ventricles. The V-SVZ is the largest germinal region in the adult mammalian brain and generates olfactory bulb interneurons and oligodendrocytes and in the case of the human brain, it could also be the source of neuroblasts and interneurons found in the adjacent striatum 27 . Thus, the finding of new molecules able to increase the neurogenic potential of the VZ-SVZ niche, especially in the case of PD patients with alterations in LRRK2 activity, is of great relevance.
To determine if some of the LRKK2 inhibitors described in Table 1 (C-D) Quantitative analysis of the neurospheres in culture. The total neurosphere area was measured (C) and the number of neurospheres was counted (D) in each field using an especially designed macro for IMAGE J. Results are mean value ± SEM, represented as relatives to control value (=100), of five different fields each one from triplicates and from three independent experiments. Bar in A: 100 µm. *p≤0.05; **p≤0.005.
Conclusions
LRRK2, an enigmatic enzyme implicated in both familial and idiopathic PD risk, may be also play an important role in adult neurogenesis through the Wnt signaling pathway.
Since the discovery of the adult neurogenesis great research efforts have been made to decipher its role and implications in health and pathological conditions.
Currently, it is recognized that aging, neurodegenerative and some mental diseases are associated with a decrease in brain neurogenesis, although the exact relevance of this decrease to disease etiology and pathogenesis remains debated. Thus, small molecules able to modulate neurogenesis and neuroplasticity, are intensively being pursued as M A N U S C R I P T
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valuable pharmacological probes and as new potential therapeutic agents for these unmet conditions or diseases 29 .
With the aim of translating these discoveries into therapeutics, we have designed new indoline-derived LRRK2 inhibitors with predicted brain permeability and determine their potential as regulators of adult neurogenesis in neural stem cells isolated from the ventricular-subventricular zone. Therefore, these inhibitors of the activity of LRRK2 may be considered as pharmacological probes to study the potential neuroregeneration of the damaged brain. Further studies are in progress to show the regenerative potential of LRRK2 inhibitors in in vivo models.
Experimental Section
Chemistry
Reagents were purchased from commercial sources and used without further purification. Melting points were determined with a Mettler Toledo MP70 apparatus.
Crude residues were purified with the indicated solvent as eluent by flash column chromatography carried out at medium pressure using silica gel (E. Merck, Grade 60, min, 100 -110 ºC). After cooling to room temperature, ethyl acetate (50 mL) was added and the mixture was extracted with a saturated solution of NaHCO 3 (50 mL x 3).
Finally, the organic phase was dried over magnesium sulfate and the solvent evaporated under reduced pressure. The residue was chromatographed as indicated in each case.
In case the amine was in hydrochloride form, the amine derivative (1 eq) was stirred with triethylamine (1 eq) and toluene (3 mL) for 1 h at room temperature. 
(E,Z)-3-((3-Nitrophenyl)imino)indolin-2-one (1):
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT (E,Z)-3-(Morpholinoimino)indolin-2-one (20):
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT (E,Z)-5-Chloro-3-(2,2-diphenylhydrazono)indolin-2-one (33):
Reagents : 
Synthesis of N-substituted compounds 22-28:
For the synthesis of these compounds we followed the procedure described by Ottoni et al. 19 In our case, the crude was purified by column chromatography using chloroform as eluent. 
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Synthesis of 28 and 29. The isatin derivative (1 eq) and NaH (1 eq) were dissolved in anhydrous DMF (20 mL), the mixture was stirred at room temperature during 2 h. After that, benzyl bromide (1 eq) was added and stirred until the reaction was finished. The solvent was removed under reduced pressure. Ethyl acetate (50 mL) was added and the organic layer was washed with a satured solution of NaCl (2 x 50 mL). After that, the organic phase was dried over magnesium sulfate and the solvent evaporated under reduced pressure. The crude was purified by column chromatography using chloroform as eluent. 
Molecular Modelling
The human LRRK2 sequence was retrieved from Swiss-Prot 48 and aligned to template structure sequence using ClustalW 49 . The percentage of identity between the kinase domain of LRRK2 and the kinase domain of Janus Kinase 2 was 26.3%. Other kinases, for instance TIE2, showed higher percentage of identity. However, they were not used as we could not reproduce with them the same environment around the catalytic residues that has been reported in the literature 24 . Finally, the model using JAK2 as template was built using Swiss-Model 50 . The model has been visualized using Sybyl-X Neurosphere (NS) cultures were derived from the subventricular zone of 4 young adult (6 weeks old) C57BL/6 mice and induced to proliferate using established passaging methods to achieve optimal cellular expansion according to published protocols 54 .
Briefly, mice were euthanized with CO 2 , brains were removed and the subventricular zone was dissected, cut up into pieces and digested using 0.7 mg/ml papain, 0.2 mg/ml cysteine and 0.2 mg/ml EDTA before it was gently disaggregated. The resulted cell suspension was plated into 8 wells of 12-well plates containing DMEM-F12
supplemented with insulin (10 mg/ml), apotransferrin, putrescine, progesterone, sodium 
Supplementary material
Elemental analysis of new compounds (Table S1 ); Experimental data of protein kinases profiling assay (Table S2) ; Representative 1H-NMR spectra of some indolinones derivatives ( Figure S1 ); Correlation between experimental and reported human BBB permeability of commercial drugs using the PAMPA-BBB assay ( Figure S2 ) together with predicted BBB permeability of indolinone derivatives (Table S3) ; Calculated physicochemical properties of some diphenylhydrazono-indolinones (Table S4) .-LRRK2 G2019S, the most common LRRK2 mutation in familial Parkinson's disease, is also potently inhibited with these novel compounds.
.-Indolinone-based LRRK2 inhibitors are brain permeable drug leads using a PAMPA methodology.
.-Pro-neurogenic effects using neuronal stem cells isolated from adult mice subventricular zone have been shown after the treatment with indolinone-based LRRK2 inhibitors .-Indolinone-based LRRK2 inhibitors may be good pharmacological tools to study neurogenesis in PD animal models.
